Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives

Cardiovascular Risk and DiseasesAtrial FibrillationHeart, Artery and Coronary DiseasesHeart FailureHypertension

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

J Am Coll Cardiol.

Scott PE, Unger EF, Jenkins MR, Southworth MR, McDowell TY, Geller RJ, Elahi M, Temple RJ, Woodcock J

doi: 10.1016/j.jacc.2018.02.070.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5

J Am Coll Cardiol

Park K, Bairey Merz CN, Bello NA, Davis M, Duvernoy C, Elgendy IY, Ferdinand KC, Hameed A, Itchhaporia D, Minissian MB, Reynolds H, Mehta P, Russo AM, Shah RU, Volgman AS, Wei J, Wenger NK, Pepine CJ, Lindley KJ, American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group.

doi: 10.1016/j.jacc.2021.01.057

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events: The ENGAGE Randomized Clinical Trial

JAMA Cardiol

Patel MS, Bachireddy C, Small DS, Harrison JD, Harrington TO, Oon AL, Rareshide CAL, Snider CK, Volpp KG

doi: 10.1001/jamacardio.2021.3176

Cardiovascular Risk and Diseases

Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5

J Am Coll Cardiol

Davis MB, Arendt K, Bello NA, Brown H, Briller J, Epps K, Hollier L, Langen E, Park K, Walsh MN, Williams D, Wood M, Silversides CK, Lindley KJ, American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group.

doi: 10.1016/j.jacc.2021.02.033

Cardiovascular Risk and Diseases

Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5

J Am Coll Cardiol

Lindley KJ, Bairey Merz CN, Asgar AW, Bello NA, Chandra S, Davis MB, Gomberg-Maitland M, Gulati M, Hollier LM, Krieger EV, Park K, Silversides C, Wolfe NK, Pepine CJ, American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group.

doi: 10.1016/j.jacc.2021.02.026

Cardiovascular Risk and DiseasesLipid-Lowering Drugs

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women

J Am Coll Cardiol.

Cook NR, Mora S, Ridker PM

doi: 10.1016/j.jacc.2018.04.060.

Heart, Artery and Coronary DiseasesHeart Failure

Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry

Circ Heart Fail

Ezekowitz J, Mentz RJ, Westerhout CM, Sweitzer NK, Givertz MM, Piña IL, O'Connor CM, Greene SJ, McMullan C, Roessig L, Hernandez AF, Armstrong PW

doi: 10.1161/CIRCHEARTFAILURE.120.008242

Lipid-Lowering Drugs

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials

JAMA Cardiol.

Sparrow RT, Khan AM, Ferreira-Legere LE, Ko DT, Jackevicius CA, Goodman SG, Anderson TJ, Stacey D, Tiszovszky I, Farkouh ME, Tu JV, Udell JA

doi: 10.1001/jamacardio.2019.3066.

Cardiovascular Risk and Diseases

Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women

doi: 10.1161/

Related content

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5

Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events: The ENGAGE Randomized Clinical Trial

Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5

Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women

Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials

Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women